Bellicum Pharmaceuticals (BLCM) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsOwnershipTrendsStock AnalysisEarningsOwnershipTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period February 22, 2024 | msn.comBellicum sells assets to MD Anderson, moves towards liquidationJanuary 25, 2024 | msn.comBellicum Pharmaceuticals Issues Super-Voting Share PrivatelyDecember 23, 2023 | morningstar.comBellicum Pharmaceuticals Inc BLCMDecember 8, 2023 | benzinga.comBellicum Pharmaceuticals Stock (OTC:BLCM), Short Interest ReportOctober 27, 2023 | finance.yahoo.comFutura Medical plc (FAMDF)July 13, 2023 | finance.yahoo.comBLCM - Bellicum Pharmaceuticals, Inc.June 3, 2023 | fool.comBellicum Pharmaceuticals (NASDAQ: BLCM)May 8, 2023 | marketbeat.comTrading was temporarily halted for "BLCM" at 09:05 AM with a stated reason of "LULD pause." Trading set to resume at 09:05 AM. May 8, 2023 | marketbeat.comTrading was temporarily halted for "BLCM" at 09:05 AM with a stated reason of "LULD pause." Trading set to resume at 09:05 AM. May 8, 2023 | investorplace.comWhy Is Bellicum Pharmaceuticals (BLCM) Stock Up 75% Today?April 18, 2023 | msn.comWhy Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving PremarketApril 18, 2023 | benzinga.comShort Volatility Alert: Bellicum PharmaMarch 15, 2023 | msn.comBLCM Plummets on Stopping Trials of BPX-601 and BPX-603March 15, 2023 | msn.comWhy Bellicum Pharmaceuticals (BLCM) Stock Is Down 48%March 14, 2023 | finance.yahoo.comBellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic AlternativesMarch 14, 2023 | marketbeat.comTrading was temporarily halted for "BLCM" at 04:03 PM with a stated reason of "News pending."February 24, 2023 | finance.yahoo.comWhy Bellicum Pharmaceuticals Stock Is Plunging TodayFebruary 16, 2023 | finance.yahoo.comBellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers SymposiumJanuary 31, 2023 | finance.yahoo.comCORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 19, 2023 | finance.yahoo.comBellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers SymposiumJanuary 6, 2023 | marketbeat.comTrading was temporarily halted for "BLCM" at 02:01 PM with a stated reason of "LULD pause."November 13, 2022 | finanznachrichten.deBellicum Pharmaceuticals, Inc.: Bellicum Reports Third Quarter 2022 Financial Results and Provides Operational UpdateNovember 10, 2022 | finance.yahoo.comBellicum Reports Third Quarter 2022 Financial Results and Provides Operational UpdateOctober 4, 2022 | finance.yahoo.comBellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting on the MesaSeptember 15, 2022 | seekingalpha.comBLCM Bellicum Pharmaceuticals, Inc.September 1, 2022 | finance.yahoo.comBellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceAugust 25, 2022 | finance.yahoo.comBellicum Pharmaceuticals (BLCM) Could Find Support Soon, Here's Why You Should Buy the Stock NowAugust 18, 2022 | finance.yahoo.comIs Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year?August 11, 2022 | finance.yahoo.comBellicum Reports Second Quarter 2022 Financial Results and Provides Operational UpdateMay 13, 2022 | seekingalpha.comBellicum Pharmaceuticals GAAP EPS of -$0.25 beats by $0.42May 13, 2022 | finance.yahoo.comBellicum Reports First Quarter 2022 Financial Results and Provides Operational UpdateMarch 24, 2022 | finance.yahoo.comBellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational UpdateFebruary 16, 2022 | benzinga.comLadenburg Thalmann Initiates Coverage On Bellicum Pharmaceuticals with Buy Rating, Announces Price Target of $5January 28, 2022 | stockhouse.comBellicum Pharmaceuticals Inc. BLCMJanuary 26, 2022 | finance.yahoo.comBellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology ConferenceDecember 13, 2021 | finance.yahoo.comBellicum Regains Compliance with Nasdaq Continued Listing RequirementsDecember 10, 2021 | finance.yahoo.comSumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021December 7, 2021 | msn.comBellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer StudiesDecember 6, 2021 | markets.businessinsider.comBellicum Reports Positive Interim Data From Phase 1/2 GoCAR-T Trials - Quick FactsDecember 6, 2021 | finance.yahoo.comBellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at MarketDecember 2, 2021 | bizjournals.comK2 BioLabs hiring, expanding contract research offerings for biotech, pharma startupsNovember 4, 2021 | finance.yahoo.comBellicum Reports Third Quarter 2021 Financial Results and Provides Operational UpdateSeptember 3, 2021 | apnews.comBellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment ...September 3, 2021 | finance.yahoo.comBellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 1, 2021 | finance.yahoo.comBellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety SwitchAugust 12, 2021 | sfgate.comBellicum Pharmaceuticals: Q2 Earnings SnapshotAugust 12, 2021 | finance.yahoo.comBellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update Get Bellicum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter. Email Address J.P. Morgan’s DIRE Warning (Ad)When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell." Click here to see why Wall Street is in PANIC mode >>> BLCM Media Mentions By Week BLCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCM News Sentiment▼0.340.61▲Average Medical News Sentiment BLCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCM Articles This Week▼00▲BLCM Articles Average Week Get Bellicum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Humanigen News Today Kaleido Biosciences News Today Alpha Tau Medical News Today Artelo Biosciences News Today BriaCell Therapeutics News Today eFFECTOR Therapeutics News Today Fortress Biotech News Today GeoVax Labs News Today Precigen News Today Unum Group News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLCM) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research.....The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellicum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellicum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLCM Stock Alerts